Study of DNA interactions with steroidal and nonsteroidal estrogen-platinum (II)-based anticancer drugs

DNA and Cell Biology

Volumn 28, Issue 1, 2009, Pages 31-39

  Froehlich, Emilie ^a   Gupta, Atul ^a   Provencher Mandeville, Josée ^a   Asselin, Éric ^a   Bariyanga, Joseph ^b   Bérubé, Gervais ^a   Tajmir Riahi, Heidar Ali ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b University of Hawaii West Oahu   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 AMINOETHYL)AMINO] 9,10,10 TRIS(4 HYDROXYPHENYL) 9 DECENE DICHLOROPLATINUM; 16 BETA HYDROXYMETHYL 16 ALPHA [8 (2 PYRIDIN 2 YL ETHYLAMINO) 3,6 DIOXAOCTYL] 1,3,5(10) ESTRATRIEN 3,17 BETA DIOL DICHLOROPLATINUM; ANTINEOPLASTIC AGENT; ATG 99; DNA; DOUBLE STRANDED DNA; GEB 28; JPM 39; PHOSPHATE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); DNA STRUCTURE; DRUG BINDING; DRUG DNA INTERACTION; DRUG STRUCTURE; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; THYMUS; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS; CIRCULAR DICHROISM; DNA; ESTROGENS; MOLECULAR STRUCTURE; NUCLEIC ACID CONFORMATION; ORGANOPLATINUM COMPOUNDS; PHOSPHORIC ACID ESTERS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 58149505868     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0804     Document Type: Article

References (33)

1. Ahmed Ouameur, A., and Tajmir-Riahi, H.A. (2004). Structural analysis of DNA interactions with biogenic polyamines and cobalt(III)hexamine studied by Fourier transform infrared and capillary electrophoresis. J Biol Chem 279, 42041-42054.
2. Alex, S., and Dupuis, P. (1989). FTIR and Raman investigation of cadmium binding by DNA. Inorg Chim Acta 157, 271-281.
3. 3+:VCD and AFM evidence of DNA condensation. Biopolymers 61, 243-260.
4. Bérubé, G. (2006). Estrogen-linked platinum (II) complexes as anticancer agents. US patent #7,153,844, December 26, 2006.
5. Bérubé, G., Wheeler, P., Ford, C.H.J., Gallant, M., and Tsaltas, Z. (1993). Synthesis and preliminary in vitro biological activity of nonsteroidal cytotoxic estrogens designed for the treatment of breast cancer. Can J Chem 71, 1327-1333.
6. Carmichael, J., DeGraff, W.G., Gazdar, A.F., Minna, J.D., and Mitchell, J.B. (1987). Evaluation of a tetrazolium-based semi-automated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47, 936-942.
7. Cepeda, V., Fuertes, M.A., Castilla, J., Alonso, C., Quevedo, C., and Pérez, J.M. (2007). Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7, 3-18.
8. Descôteaux, C., Provencher-Mandeville, J., Mathieu, I., Perron, V., Mandal, S.K., Asselin É., and Bérubé, G. (2003). Synthesis of 17β-estradiol platinum (II) complexes: biological evaluation on breast cancer cell lines. Bioorg Med Chem Lett 13, 3927-3931.
9. Dovbeshko, G.I., Chegel, V.I., Gridina, N.Y., Repnytska, O.P., Shirshov, Y.M., Tryndiak, V.P., Todor, I.M., and Solyanik, G.I. (2002). Surface enhanced IR absorption of nucleic acids from tumor cells: FTIR reflectance study. Biopolymers 67, 470-486.
10. Gagnon, V., St-Germain, M.-È., Descôteaux, C., Provencher-Mandeville, J., Parent, S., Mandal, S.K., Asselin, É., and Bérubé, G. (2004). Biological evaluation of novel estrogen-platinum (II) hybrid molecules on uterine and ovarian cancers - molecular modeling studies. Bioorg Med Chem Lett 14, 5919-5924.
11. Galanski, M., and Keppler, B.K. (2007). Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in tumor tissue. Anticancer Agents Med Chem 7, 55-73.
12. Gupta, A., Mandal, S.K., Leblanc, V., Descôteaux, C., Asselin, E., and Bérubé, G. (2008). Synthesis and cytotoxic activity of benzopyran-based platinum (II) complexes. Bioorg Med Chem Lett 18, 3982-3987.
13. Gust, R., and Ott, I. (2007). Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment. Anticancer Agents Med Chem 7, 95-110.
14. Jamieson, E.R., and Lippard, S.J. (1999). Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99, 2467-2472.
15. Kankia, B.I., Bukin, V., and Bloomfield, V.A. (2001). Hexamine cobalt (III)-induced condensation of calf-thymus DNA: circular dichroism and hydration measurements. Nucleic Acids Res 29, 2795-2801.
16. Kelland, L.R., and Farrell, N.P. (2000). Platinum-Based Drugs in Cancer Therapy (Humana Press, Totowa, NJ).
17. Kypr, J., and Vorlickova, M. (2002). Circular dichroism spectroscopy reveals invariant conformation of guanine runs in DNA. Biopolymers 67, 275-277.
18. Loprete, D.M., and Hartman, K.A. (1993). Conditions for the stability of the B, C, and Z structural forms of poly(dG-dC) in the presence of lithium, potassium, magnesium, calcium and zinc cations. Biochemistry 32, 4077-4082.
19. Nafisi, Sh., Saboury, A.A., Keramat, N., Neault, J.F., and Tajmir-Riahi, H.A. (2007). Stability and structural features of DNA intercalation with ethidium bromide, acridine orange and methylene blue. J Mol Struct 827, 35-43.
20. Nejedly, K., Chladkova, J., Vorlickova, M., Hrabcova, I., and Kypr, J. (2005). Mapping the B-A conformational transition along plasmid DNA. Nucleic Acids Res 33, No. 1e 5, 1-8.
21. N'soukpoé-Kossi, C.N., Descôteaux, C., Asselin, E., Bérubé, G., and Tajmir-Riahi, H.A. (2008). DNA interaction with novel antitumor estradiol-platinum (II) hybrid molecule: a comparative study with cisplatin drug. DNA Cell Biol 27, 101-107.
22. Perron, V., Rabouin, D., Asselin, É., Parent, S., C.-Gaudreault, R., and Bérubé, G. (2005). Synthesis of 17α-estradiol-linked platinum (II) complexes and their cytocidal activity on estrogen-dependent and independent breast tumor cells. Bioorg Chem 33, 1-15.
23. Potaman, V.N., Bannikov, Y.A., and Shlyachtenko, L.S. (1980). Sedimentation of DNA in ethanol-water solution within the interval of B to A transition. Nucleic Acids Res 8, 635-642.
24. Provencher-Mandeville, J., Descôteaux, C., Mandal, S.K., Leblanc, V., Asselin, E., and Bérubé, G. (2008). Synthesis of 17β-estradiol-platinum (II) hybrid molecules showing cytotoxic activity on breast cancer cell lines. Bioorg Med Chem Lett 18, 2282-2287.
25. Reedijk, J. (1992). The relevance of hydrogen bonding in the mechanism of action of platinum antitumor compounds. Inorg Chim Acta 198, 873-881.
26. Rosenberg, B., van Camp, L., and Krigas, T. (1965). Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205, 698-699.
27. Stephanos, J.J. (1996). Drug-protein interactions: two-site binding of heterocyclic ligands to a monomeric hemoglobin. J Inorg Biochem 62, 155-169.
28. Stephanos, J.J., Farina, S.A., and Addison, A.W. (1996). Iron ligand recognition by monomeric hemoglobins. Biochim Biophys Acta 1295, 209-221.
29. Taillandier, E., and Liquier, J. (1992). Infrared spectroscopy of DNA. Methods Enzymol 211, 307-335.
30. Vijayalakshmi, R., Kanthimathi, M., Subramanian, V., and Balachandran, U.N. (2000). DNA cleavage by a chromium (III) complex. Biochem Biophys Res Commun 271, 731-734.
31. Vorlickova, M. (1995). Conformational transitions of alternating purin-pyrimidin DNAs in perchlorate ethanol solutions. Biophys J 69, 2033-2043.
32. Wheeler, P., and Bérubé, G. (1993). The synthesis of new platinum (II) complexes linked to nonsteroidal estrogens. Inorg Chim Acta 209, 97-100.
33. Wong, E., and Giandomenico, C.M. (1999). Current status of platinum-based antitumor drugs. Chem Rev 99, 2451-2466.